Department of Medicine, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY, USA.
Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
J Geriatr Oncol. 2024 Sep;15(7):101840. doi: 10.1016/j.jgo.2024.101840. Epub 2024 Aug 1.
Timely incorporation of palliative care (PC) during treatment of patients with metastatic cancers can improve symptom management and quality of life. Older age has been associated with lower PC use in patients with cancer. The frequency by which older patients with metastatic breast cancer (MBC) receive PC is unknown. The goal of this study was to use the National Cancer Database (NCDB) to describe national patterns in PC use in older adults over 75 years of age with MBC.
Females with a diagnosis of MBC at age ≥ 75 years from 2010 to 2019 were identified from the NCDB. The NCDB defined PC as any surgery, radiation, systemic therapy, and/or pain management that was administered with noncurative intent. Multivariable logistic regression models were performed to assess associations between PC receipt and study covariates.
Of 17,325 eligible participants included in the final analysis, 39.4% were 75-79, 30.1% 80-84, and 30.4% ≥ 85 years of age. Overall, 22.1% (N = 3824) of patients utilized PC, of whom 14.3% received pain management, while the remainder received palliative intent surgery, radiation, and/or systemic therapy. Patients who were Hispanic were less likely to receive PC (AOR: 0.62, 95% CI: 0.48-0.79), p < 0.001). In the overall population, the use of PC increased from 19.2% in 2010 to 25.3% in 2019, though this was primarily driven by the statistically significant increase in the 75-79 age group (19.9% to 28.1%, p = 0.001).
In this patient population from the NCDB, we observed an increase in PC utilization over the last decade in older adults with MBC, though the increase was lowest in patients who were 85 years and older. Barriers to PC in older adults with cancer need to be further explored.
在转移性癌症患者的治疗过程中及时纳入姑息治疗(PC)可以改善症状管理和生活质量。年龄较大与癌症患者接受 PC 的比例较低有关。尚不清楚接受转移性乳腺癌(MBC)治疗的老年患者接受 PC 的频率。本研究的目的是利用国家癌症数据库(NCDB)描述 2010 年至 2019 年间≥75 岁的 MBC 老年患者中 PC 使用的全国模式。
从 NCDB 中确定了年龄≥75 岁且诊断为 MBC 的女性。NCDB 将 PC 定义为具有非治愈意图的任何手术、放疗、全身治疗和/或疼痛管理。进行多变量逻辑回归模型以评估 PC 接受与研究协变量之间的关联。
最终分析纳入了 17325 名符合条件的参与者,其中 39.4%为 75-79 岁,30.1%为 80-84 岁,30.4%为≥85 岁。总体而言,22.1%(N=3824)的患者接受了 PC,其中 14.3%接受了疼痛管理,其余患者接受了姑息治疗手术、放疗和/或全身治疗。西班牙裔患者接受 PC 的可能性较低(AOR:0.62,95%CI:0.48-0.79),p<0.001)。在整个人群中,2010 年至 2019 年 PC 的使用率从 19.2%增加到 25.3%,尽管这主要是由于 75-79 岁年龄组的统计学显著增加(19.9%至 28.1%,p=0.001)。
在 NCDB 的这个患者群体中,我们观察到过去十年中 MBC 老年患者 PC 的使用率有所增加,尽管 85 岁及以上患者的增幅最低。需要进一步探讨癌症老年患者接受 PC 的障碍。